recurrent pregnancy loss
DESCRIPTION
The Relationship between Factor V Leiden Mutation and Recurrent Abortion Among Palestinian Pregnant Women In The West Bank Ayman Hussein An-Najah National University. Recurrent Pregnancy loss Defined as 3 or more spontaneous fetal losses before the 20 th week of pregnancy . - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Recurrent Pregnancy loss](https://reader036.vdocument.in/reader036/viewer/2022070401/5681362b550346895d9da613/html5/thumbnails/1.jpg)
The Relationship between Factor V Leiden Mutation and Recurrent Abortion Among
Palestinian Pregnant Women In The West Bank
Ayman HusseinAn-Najah National University
1
![Page 2: Recurrent Pregnancy loss](https://reader036.vdocument.in/reader036/viewer/2022070401/5681362b550346895d9da613/html5/thumbnails/2.jpg)
Recurrent Pregnancy loss
Defined as 3 or more spontaneous fetal losses before the 20th week of pregnancy .
A major health problem affecting 0.5%-1.0% of pregnant women
occurring in about 20 % of all pregnancies, fewer than 50% of these cases have definitive causes .
2
![Page 3: Recurrent Pregnancy loss](https://reader036.vdocument.in/reader036/viewer/2022070401/5681362b550346895d9da613/html5/thumbnails/3.jpg)
Thrombophilia• It is a predisposition to thrombosis.
• It is a multigenic disorder caused by inherited and acquired factors
• it contributes to the increasing incidence of poor pregnancy outcomes including recurrent abortion .
3
![Page 4: Recurrent Pregnancy loss](https://reader036.vdocument.in/reader036/viewer/2022070401/5681362b550346895d9da613/html5/thumbnails/4.jpg)
Factor V Factor V protein 330 k Da made
chiefly by cells in the liver ,circulates in plasma as a single-chain molecule with a plasma half-life of about 12 hours1984).
In contrast to most other coagulation factors, it is not enzymatically active but functions as a cofactor
4
![Page 5: Recurrent Pregnancy loss](https://reader036.vdocument.in/reader036/viewer/2022070401/5681362b550346895d9da613/html5/thumbnails/5.jpg)
5
Pregnant women have 2–5-fold higher risk for venous thromboembolism (VTE )compared to non-pregnant women.
The FVL variant allele increases the risk for (VTE) during pregnancy 8–10
times, compared to non-pregnant women with the wild-type genotype .
![Page 6: Recurrent Pregnancy loss](https://reader036.vdocument.in/reader036/viewer/2022070401/5681362b550346895d9da613/html5/thumbnails/6.jpg)
Factor VProcoagulant and Anticoagulant Actions of Factor V.
Procoagulant : , factor Va enhances the activation of prothrombin (factor II) by factor Xa.
Anticoagulant :Factor V can serve (with protein S) as a cofactor in the inactivation of factor VIIIa by activated protein C (APC)
GroupTotal No
NO
Of
women
%
OF
mutatio
n
% Mutation genotypeComparison with the
control group
homohetroP valueOdds
ratio95% CI
Control
group
50
11
(22 %)0%22%0.5942.787(2.1575,
3.4165)
Primary
abortion
32/548(25.0
%)6.30%18.70%
Seconda
ry
abortion
22/54
7
31.8%0%31.80%
6
![Page 7: Recurrent Pregnancy loss](https://reader036.vdocument.in/reader036/viewer/2022070401/5681362b550346895d9da613/html5/thumbnails/7.jpg)
04/20/23 شلباية خالد 7
![Page 8: Recurrent Pregnancy loss](https://reader036.vdocument.in/reader036/viewer/2022070401/5681362b550346895d9da613/html5/thumbnails/8.jpg)
Factor V Leiden mutationInheritance is autosomal dominant. Heterozygous :4.5-14.5% Homozygous : 1:5000Present in 4 to 10% of people of Caucasian
origin (Bertina et al 1994; Rees 1996).The most common cause of inherited
thrombophilia, accounting for 20% to 50% of cases (Bertina et al 1994).
Both homo. and heterozygous individuals with the mutation can develop thrombosis. Homo have 91 times increase in thrombosis .
8
![Page 9: Recurrent Pregnancy loss](https://reader036.vdocument.in/reader036/viewer/2022070401/5681362b550346895d9da613/html5/thumbnails/9.jpg)
ObjectiveThe main objective of our study was :
To investigate if there is a significant association between factor V Leiden mutation and Recurrent Abortion among Palestinian Pregnant Women In the West Bank.
9
![Page 10: Recurrent Pregnancy loss](https://reader036.vdocument.in/reader036/viewer/2022070401/5681362b550346895d9da613/html5/thumbnails/10.jpg)
Methodology Case Control Study Design
Data collection : Uniformed questionnaire & direct contact . ( Specific Inclusion & exclusion criteria's ).
Research Place: the Medical Centres in West Bank
Ethical consideration: approved by the Research and Ethical Committee in An-Najah University and Alquds University.
Sample processing: 1-Blood sample collection ( Three medical centers ) 2-Genomic DNA Purification (Master Pure TM
Genomic DNA Purification Kit) .
3-Genomic DNA Qualification (Agarose gel electrophoresis )
10
![Page 11: Recurrent Pregnancy loss](https://reader036.vdocument.in/reader036/viewer/2022070401/5681362b550346895d9da613/html5/thumbnails/11.jpg)
Genomic DNA Qualification (Agarose
gel .electrophoresis
Lanes 1-6 contain separate DNA samples (1 ul)
Lane 7 contains 100 Base Pair DNA Ladder as size marker.
*
Figure 2.1 Agarose gel electrophoresis For Genomic
DNA
11
1234567
![Page 12: Recurrent Pregnancy loss](https://reader036.vdocument.in/reader036/viewer/2022070401/5681362b550346895d9da613/html5/thumbnails/12.jpg)
Identification of Mutation PCR & ARMS Test
ARMS Test :One of the basic methods of DNA assaysIt is an accurate, rapid and simple method (amplification +diagnostic steps are combines). . ***
The use of allele-specific primers for PCR amplification
RES
12
![Page 13: Recurrent Pregnancy loss](https://reader036.vdocument.in/reader036/viewer/2022070401/5681362b550346895d9da613/html5/thumbnails/13.jpg)
Gel electrophoresis for Leiden mutation PCR product analysis
Ula Abu Hilal. 13
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
![Page 14: Recurrent Pregnancy loss](https://reader036.vdocument.in/reader036/viewer/2022070401/5681362b550346895d9da613/html5/thumbnails/14.jpg)
04/20/23 14
![Page 15: Recurrent Pregnancy loss](https://reader036.vdocument.in/reader036/viewer/2022070401/5681362b550346895d9da613/html5/thumbnails/15.jpg)
04/20/23 15
![Page 16: Recurrent Pregnancy loss](https://reader036.vdocument.in/reader036/viewer/2022070401/5681362b550346895d9da613/html5/thumbnails/16.jpg)
ResultsObstetric History Case group: 191 women (at least 3 RA ).Control group: 205 women (gave normal birth
for at least two babies). Data indicates that both groups show basically
similar distribution according to Age , BMI values & usage of OCPs.
The prevalence of Thromboembolic events among relatives of the case group (18.5 %) was higher than. that among relatives of the control group (2 %) ( P= (0.006
16
![Page 17: Recurrent Pregnancy loss](https://reader036.vdocument.in/reader036/viewer/2022070401/5681362b550346895d9da613/html5/thumbnails/17.jpg)
Characteristics of study participants. Cases
Controls No % No
%Age (y) 32.0 - 31.9 -Marriage age (y) 19.3 - 18.8 -Regional Camp 115.0 60.0 141.0 69.0
City 47.0 24.7 40.0 19.4 Village 29.0 15.3 24.0 11.6Smokers 19.0 10.0 19.0 10.0Education level Low 153.0 79.5 166.0 81.3 High 38.0 20.5 39.0 18.7BMI*
Normal 55.0 29.2 61.0 30.0 Overweight 76.0 40.1 63.0 30.7 Obese 57.0 30.7 70.0 34.2Abortion 78.0 43.0 0.0 0.0
![Page 18: Recurrent Pregnancy loss](https://reader036.vdocument.in/reader036/viewer/2022070401/5681362b550346895d9da613/html5/thumbnails/18.jpg)
Leiden Mutation Prevalence among participants.
![Page 19: Recurrent Pregnancy loss](https://reader036.vdocument.in/reader036/viewer/2022070401/5681362b550346895d9da613/html5/thumbnails/19.jpg)
![Page 20: Recurrent Pregnancy loss](https://reader036.vdocument.in/reader036/viewer/2022070401/5681362b550346895d9da613/html5/thumbnails/20.jpg)
Mutation
1st trimester aborters
(n=66)
Controls(n=155)
Odd RatioP-value
Leiden mutation
14( 21.2%)13( 8.4%)2.941.012
![Page 21: Recurrent Pregnancy loss](https://reader036.vdocument.in/reader036/viewer/2022070401/5681362b550346895d9da613/html5/thumbnails/21.jpg)
Mutation
2d trimester aborters
(n=25)
Controls(n=155)
Odd RatioP-value
Leiden mutation
12( 48%)13( 8.4%)10.083.000
![Page 22: Recurrent Pregnancy loss](https://reader036.vdocument.in/reader036/viewer/2022070401/5681362b550346895d9da613/html5/thumbnails/22.jpg)
MutationIUFD
(n=26)Controls
(n=155)Odd RatioP-value
Leiden mutation
8( 30.8)% 13( 8.4%)4.855.001
![Page 23: Recurrent Pregnancy loss](https://reader036.vdocument.in/reader036/viewer/2022070401/5681362b550346895d9da613/html5/thumbnails/23.jpg)
MutationPIH
(n=20)Controls
(n=155)Odd RatioP-value
Leiden mutation
1( 5%)13( 8.4%).5751
![Page 24: Recurrent Pregnancy loss](https://reader036.vdocument.in/reader036/viewer/2022070401/5681362b550346895d9da613/html5/thumbnails/24.jpg)